<div id="readability-page-1">11:27 AM EST, 12/18/2025 (MT Newswires) -- Lixte Biotechnology ( LIXT ) said Thursday that it launched an approximately $4.3 million registered direct offering of common stock along with pre-funded and investor warrants at $4.09 per unit.The offering consisted of about 1.1 million units, each including one share of common stock or a pre-funded warrant, plus one common warrant to buy one common share per warrant, the company said.Net proceeds will be used for general corporate purposes and working capital, the company said.The offering is expected to close by Friday.Lixte Biotechnology ( LIXT ) shares were down over 2% in recent trading.Price: 3.87, Change: -0.09, Percent Change: -2.40 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

LIXT

Lixte Biotechnology announced a $4.3 million registered direct offering of common stock, including pre-funded and investor warrants at $4.09 per unit. The offering comprises about 1.1 million units, each with one share of common stock or a pre-funded warrant, plus one common warrant. Proceeds will be used for general corporate purposes and working capital. The offering is expected to close by Friday. Lixte Biotechnology shares fell over 2% in recent trading.

Lixte Biotechnology Launches $4.3 Million Registered Direct Offering